.
.
.
What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
Petrini P. Petrini P.
.
Item in Clipboard
Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy.
- Gluten intolerance a significant risk factor
- Infectious disease of the uterus
- Absence of an individual specific disease